[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346369-105":59,"doc-detail-346369-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","identification-of-prognostic-markers-related-to-homologous-recombination-deficiency-in-cholangiocarcinoma-coxboost-and-lasso-machine-learning-techniques","Identification of prognostic markers related to homologous recombination deficiency in cholangiocarcinoma - CoxBoost and LASSO machine learning techniques","","Cholangiocarcinoma (CHOL) is an aggressive digestive-tract malignancy with poor outcomes, and homologous recombination deficiency (HRD) is linked to genomic instability and tumor progression. This study develops HRD-based prognostic biomarkers and constructs an HRD-driven risk prediction model to support precision medicine. HRD was assessed across multiple cancer datasets, HRD scores were computed, and differential HRD-related genes were validated using RT-PCR in tumor and adjacent non-tumor tissues. CoxBoost and LASSO produced an optimal model, identifying six candidate prognostic genes with potential therapeutic relevance.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-prognostic-markers-related-to-homologous-recombination-deficiency-in-cholangiocarcinoma-coxboost-and-lasso-machine-learning-techniques/346369/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-prognostic-markers-related-to-homologous-recombination-deficiency-in-cholangiocarcinoma-coxboost-and-lasso-machine-learning-techniques/346369.png","ImageObject",300,407,{"name":92,"@type":93},"Himbo","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does this study address in cholangiocarcinoma (CHOL)?","Question",{"text":112,"@type":113},"CHOL has high malignancy and poor prognosis, with limited effective molecular prognostic markers. The study aims to identify HRD-related prognostic biomarkers and build a risk prediction model for more precise clinical guidance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was homologous recombination deficiency (HRD) evaluated and used in the analysis?",{"text":117,"@type":113},"HRD was analyzed across cancers using multiple datasets, with HRD scores calculated from referenced data. The work also uses mutation visualization and tumor mutational burden (TMB) computation to support the study’s HRD and genomic instability assessments.",{"name":119,"@type":110,"acceptedAnswer":120},"Which machine-learning methods were found to be the best combination for the prognostic model?",{"text":121,"@type":113},"The study identifies CoxBoost and LASSO as the optimal combination, yielding a CoxBoost+LASSO prognostic model for CHOL risk prediction.",{"name":123,"@type":110,"acceptedAnswer":124},"What prognostic and biological signals were associated with high versus low HRD risk groups?",{"text":125,"@type":113},"Higher HRD scores independently predicted worse overall survival and progression-free interval. Immune infiltration analysis showed different immune landscapes, including higher levels of active B cells and regulatory T cells in the low-risk group, and six genes with significant differential expression were identified as candidates.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},346369,1790510679,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","TYPE Original Research PUBLISHED 21 January 2026  \nDOI 10.3389/fimmu.2026.1615657  \nOPEN ACCESS  \nEDITED BY  \nZhaohui Tang,  \nShanghai Jiao Tong University, China  \nREVIEWED BY  \nJingtao Qiu,  \nStanford University, United States Tamer A. Addissouky,  \nUniversity of Menouﬁa, Egypt  \n*CORRESPONDENCE  \nYongqiang Zhu  \n [pt10840@shutcm.edu.cn](pt10840@shutcm.edu.cn)[ ](pt10840@shutcm.edu.cn)Wei Li  \n [liwei1825@shutcm.edu.cn](liwei1825@shutcm.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 21 April 2025  \nREVISED 18 June 2025  \nACCEPTED 08 January 2026  \nPUBLISHED 21 January 2026  \nCITATION  \nLiu Y, Zhou C, Shen T, Yu X, Li Q, Jiang T, Li W and Zhu Y (2026) Identiﬁcation of prognostic markers related to homologous recombination deﬁciency incholangiocarcinoma using CoxBoost and LASSO machine learning techniques.  \nFront. Immunol. 17:1615657 .  \ndoi: 10.3389/fimmu.2026.1615657  \nCOPYRIGHT  \n© 2026 Liu, Zhou, Shen, Yu, Li, Jiang, Li and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nIdentiﬁcation of prognostic markers related to homologous recombination deﬁciencyin cholangiocarcinoma  \nusing CoxBoost and LASSO machine learning techniques  \nYan Liu 1†, Cheng Zhou 1†, Tianhao Shen 1, Xue Yu 1, Qiuying Li 1, Tinghui Jiang1, Wei Li 2* and Yongqiang Zhu 1*  \n1Oncology Intervention Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China, 2 Hepatopancreatobiliary Surgery Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China  \nBackground: Cholangiocarcinoma (CHOL) is a highly aggressive malignancy with a poor prognosis. Homologous recombination deﬁciency (HRD) is associated with genomic instability and cancer progression, making it a potential therapeutic target. The aim of this study is to develop novel potential prognostic biomarkers and construct an HRD-based prognostic risk prediction model for CHOL to enhance clinical precision medicine.  \nMethods: We analyzed HRD across cancers using multiple datasets including TCGA-CHOL, TCGA-LIHC, GDC TARGET-OS, and IMvigor210 . HRD scores were calculated using data from Thorsson et al. and the maftools R package was used for mutation data visualization and tumor mutational burden (TMB) calculation. Differential gene expression analysis identiﬁed HRD-related genes, validated in tumor and adjacent non-tumor tissues using RT-PCR. 10 machine-learning algorithms including RSF, LASSO, GBM, Survival-SVM, SuperPC, Ridge, plsRcox, CoxBoost, Stepwise Cox, Enet were selected to construct a prognostic model and validated in the E-MTAB-6389 and GSE107943 . Among them, RSF, LASSO, CoxBoost and Stepwise Cox have the functions of dimension reduction and variable screening.  \nResults: Comparative analysis demonstrated signiﬁcant associations between HRD scores and genomic instability markers. High HRD scores independently predicted poorer overall survival (log-rank p = 0.043) and progression-free interval (log-rank p = 0 . 028) . Immune inﬁltration analysis revealed higher levels of active B cells and regulatory T cells in the low-risk group, suggesting differential immune landscapes between risk groups . We identiﬁed the CoxBoost and LASSO algorithms as the optimal combination for creating a CoxBoost+ LASSO prognostic model. Using this model, we identiﬁed six genes (ANXA2P1, BBOX1, KLHL33, MN1, OR51A4, and TRDN) with signiﬁcant differential expression.  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nConclusions: Our HRD-based prediction model offers a reliable tool for CHOL prognosis, su","cbCairLcGyrAwIE1","https://ap.wps.com/l/cbCairLcGyrAwIE1","pdf",11286386,17,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Key findings\n## HRD and genomic instability\n## Immune infiltration differences\n## Prognostic model construction\n## Candidate prognostic genes","[{\"question\":\"What problem does this study address in cholangiocarcinoma (CHOL)?\",\"answer\":\"CHOL has high malignancy and poor prognosis, with limited effective molecular prognostic markers. The study aims to identify HRD-related prognostic biomarkers and build a risk prediction model for more precise clinical guidance.\"},{\"question\":\"How was homologous recombination deficiency (HRD) evaluated and used in the analysis?\",\"answer\":\"HRD was analyzed across cancers using multiple datasets, with HRD scores calculated from referenced data. The work also uses mutation visualization and tumor mutational burden (TMB) computation to support the study’s HRD and genomic instability assessments.\"},{\"question\":\"Which machine-learning methods were found to be the best combination for the prognostic model?\",\"answer\":\"The study identifies CoxBoost and LASSO as the optimal combination, yielding a CoxBoost+LASSO prognostic model for CHOL risk prediction.\"},{\"question\":\"What prognostic and biological signals were associated with high versus low HRD risk groups?\",\"answer\":\"Higher HRD scores independently predicted worse overall survival and progression-free interval. Immune infiltration analysis showed different immune landscapes, including higher levels of active B cells and regulatory T cells in the low-risk group, and six genes with significant differential expression were identified as candidates.\"}]","Identification of prognostic markers related to homologous recombination deficiency in cholangiocarcinoma - CoxBoost and LASSO machine learning techniques | PDF",1790061129,43,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8eedf16dd82752824075274e68c62a85.webp",983,1389,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bda1104eeaf4c509b7eb7055fa0219d.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/720fdc741dd626a5767e936e9c102781.webp",981,1386,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a267d2b0b40d8280817b1fc265bc8de.webp",980,1385]